Levetiracetam G.L. (Levetiracetam)

Levetiracetam works by binding to the synaptic vesicle protein SV2A, which plays a crucial role in neurotransmitter release. This binding modulates synaptic transmission, decreasing neuronal excitability and stabilizing abnormal electrical activity that can lead to seizures.

The dosage of Levetiracetam G.L. is individualized. A qualified prescriber determines the appropriate dose based on the patient’s age, weight, renal function, seizure type, and response to therapy. Patients should follow the prescribing clinician’s instructions and not adjust the dose on their own.

Safety data for levetiracetam in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits and risks before prescribing to pregnant or nursing women. Women should discuss any concerns with their physician, who can decide if the medication is appropriate.

To order Levetiracetam G.L., submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from many traditional antiepileptics that modulate sodium channels or GABA receptors. It is generally well‑tolerated, has few drug‑enzyme interactions, and does not require routine therapeutic drug monitoring, making it a convenient option for many patients.

Levetiracetam G.L. should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency throughout its shelf life.

Levetiracetam G.L. is administered orally, usually as tablets or oral solution, according to the prescriber’s instructions. It can be taken with or without food, and the dose may be divided throughout the day depending on the treatment plan.

Serious risks include severe allergic reactions such as anaphylaxis, mood disturbances like depression or suicidal thoughts, and rare skin conditions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience rash, swelling, mood changes, or any signs of an allergic response.

Levetiracetam G.L. is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking medications that may significantly reduce its effectiveness.